Abstract
MRI was used to study the effects of introducing cidofovir (HPMPC, Vistide) to the antiretroviral therapy of a 33-year-old white man diagnosed as having progressive multifocal leukoencephalopathy (PML) secondary to AIDS. In response to combined cidofovir and antiretroviral therapy he showed significant clinical improvement. MRI showed a decrease in extent of existing lesions, without new ones. Blood chemistry information obtained indicated some involvement of immunologic mechanisms: the CD4:8 ratio showed improvement from an average of 0.08 before treatment to 0.13 during therapy.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 24 January 2000 Accepted: 6 September 2000
Rights and permissions
About this article
Cite this article
Cardenas, R., Cheng, K. & Sack, K. The effects of cidofovir on progressive multifocal leukoencephalopathy: an MRI case study. Neuroradiology 43, 379–382 (2001). https://doi.org/10.1007/s002340000495
Issue Date:
DOI: https://doi.org/10.1007/s002340000495